Gallantt Ispat Q2 FY27 Results: Revenue Up 13% in 2026
Ask Iris
Board clears unaudited results for September quarter
Gallantt Ispat Ltd informed the BSE about the outcome of its Board of Directors meeting held on Monday, October 19, 2026. The board approved the company’s unaudited financial results for the quarter and half-year ended September 30, 2026. The disclosure places the update in the context of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also submitted a limited review report from its statutory auditors along with the financial statements. The filing notes that the results were made available on the company’s website and on stock exchange platforms. For investors, the board outcome provides the official confirmation of numbers that drive near-term performance assessment.
What the company disclosed on BSE
As per the BSE announcement timestamped October 20, 2026 at 01:10 AM IST, the communication covered the approval of unaudited financial results. The company had earlier informed the exchange that a board meeting was scheduled on October 19, 2026 to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026. The stated purpose in the intimation was financial results. The disclosures are part of routine regulatory compliance for quarterly and half-yearly reporting. They also help the market track whether any changes are being communicated through outcomes, attachments, and auditor reviews.
Meeting schedule and duration
The board meeting that approved the results began at 04:30 PM and concluded at 11:00 PM on October 19, 2026, according to the company’s outcome note. The timing matters because it establishes when approvals were granted and when filings were expected. It also indicates the board considered and finalised the reporting package and related documentation during the session. The outcome is positioned as the official record of approvals for the quarter and half-year reporting period ending September 30, 2026.
Q2 FY27 performance: revenue growth but profit decline
In the same set of disclosures, Gallantt Ispat reported a 13% year-on-year increase in consolidated revenue to ₹1,145.89 crore for Q2 FY27. Despite the topline growth, net profit declined 32% year-on-year to ₹60.51 crore. The company attributed the pressure on profitability to higher costs, citing an increase in total expenses to ₹1,080.87 crore. The combination points to margin compression during the quarter even as revenue expanded. These figures were presented as part of the board meeting outcome disclosures.
Total income figures and half-year numbers
The filings also mention that total income for Q2 FY27 stood at ₹1,164.04 crore, up 13% year-on-year, alongside the net profit figure of ₹60.51 crore. For the half-year ended September 2026, the company reported total income of ₹2,328.02 crore and a net profit of ₹184.18 crore. Half-year reporting is useful because it smooths quarter-to-quarter volatility and offers a wider view of performance. However, the quarter’s cost increase is still relevant because it can influence how investors interpret sustainability of earnings.
Auditor limited review and compliance trail
Gallantt Ispat submitted the limited review report from its statutory auditors, M/s Singhi & Co., Chartered Accountants, along with the unaudited results. The company said the board reviewed and approved the results in line with SEBI LODR requirements. For market participants, the limited review attachment is part of the credibility framework around quarterly unaudited numbers. It also signals that the company has completed the procedural steps expected for such disclosures.
Key numbers at a glance
Recent corporate calendar references in disclosures
Beyond the October outcome, the shared corporate schedule entries also list other meetings and general meetings across 2026. These entries include board meetings for quarterly results and other corporate actions. While the disclosures do not provide detailed outcomes for each line item in the schedule excerpt, they indicate the cadence of reporting and shareholder meetings.
Market impact: what the numbers imply, without guessing
The disclosed Q2 FY27 pattern is clear: revenue and total income rose year-on-year, but profit fell sharply. With total expenses at ₹1,080.87 crore against total income of ₹1,164.04 crore for the quarter, the cost base was a key swing factor in profitability for this period. Investors typically use such filings to compare operating efficiency across quarters and to reconcile revenue growth with earnings delivery. Because the disclosure does not provide segment-wise drivers or detailed expense break-up in the provided text, any attribution beyond the reported expense increase would be speculative. Still, the release gives the market hard reference points for evaluating margins and earnings quality over the quarter and half-year.
Why this board outcome matters
Board approvals and exchange filings are the formal mechanism through which quarterly results enter the public domain. The October 19 meeting outcome confirms that the company completed the required governance steps and submitted the limited review report alongside unaudited numbers. It also provides a time-stamped compliance trail, including meeting duration, which is often checked by analysts tracking reporting discipline. The half-year numbers, in particular, will be used by investors to assess whether the profit drop in Q2 is offset by stronger performance in the other quarter of the half-year.
Closing note
Gallantt Ispat’s latest regulatory filings centre on the board’s approval of unaudited results for the quarter and half-year ended September 30, 2026, backed by the statutory auditor’s limited review. The key headline from the disclosure is 13% year-on-year growth in Q2 consolidated revenue to ₹1,145.89 crore alongside a 32% decline in net profit to ₹60.51 crore. The next set of exchange updates will typically depend on subsequent scheduled board meetings and any further filings the company makes on the results and related documents.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q2 Earnings Tracker